The Dutch Foundation for Technical Sciences (STW) has granted about EUR 1.5 million to the following groups: Analytical Biochemistry at the University of Groningen (Prof. R. Bischoff), Biomedical Analysis at Utrecht University (Prof. G.J. de Jong) and Biomolecular Analysis at the VU University Amsterdam (Prof. H. Irth and Prof. W.M.A. Niessen). They will be cooperating in this project with Prof. W.J. Quax (Pharmaceutical Biology, University of Groningen) and Prof. M.J. Smit (Receptor Biochemistry and Medicinal Chemistry, VU). Moreover, different companies will support this project with a total contribution of about EUR 0.8 million.
The development of biopharmaceuticals (pharmaceutical proteins) is crucial for the pharmaceutical and biotechnological industry as breakthroughs are expected from these types of products. Insulin is the most well-known pharmaceutical protein and has been used successfully for many years. Monoclonal antibodies, which are also produced in cell cultures, are particularly promising for the treatment of certain forms of cancer. Other modern biopharmaceuticals are human growth hormone and cytokines such as interferons. These proteins have very complex structures and require new technologies for their analysis. This collaborative project aims at developing such techniques for the screening of new receptor agonists and antagonists, for the analysis of biological samples to study the fate of biopharmaceuticals in the body and for the characterization of pharmaceutical proteins (heterogeneity, impurities, and degradation products). The consortium combines extensive expertise in these fields and has advanced equipment at its disposal to use in this project. Moreover, new technologies and systems will be developed and applied. Funding was approved because the application combines scientific novelty with extensive potential for real-life applications and both these aspects were considered to be excellent.
Prof. Jacquelien Scherpen, Director of the Groningen Engineering Center, at the Faculty of Science and Engineering (UG), has been voted Engineer of the Year 2023 by the expert jury. She received the Prince Friso Engineering Award 2023 yesterday, 15...
On March 15, 2023, the Slovak University of Technology in Bratislava awarded the title of "Doctor honoris causa" to Nobel laureate Ben Feringa from the Stratingh Institute for Chemistry (University of Groningen).
Prof. Andreas Milias-Argeitis of the Groningen Biomolecular Sciences and Biotechnology Institute (GBB, University of Groningen) has been awarded an Open Competition Science-M grant by the Dutch Research Council (NWO). He receives an M1 grant of EUR...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information